C
Power Law company profile
Calliditas
Biotech & Life Sciences · Stockholm, Sweden · Founded 1992 · IPO 2018 Unicorn
Valuation
$1.05B
Market cap · 2026
Revenue
$420M
Latest reported FY
Global footprint
Where Calliditas has talent and traffic
Web traffic by country
3.4K
monthly visits
across markets
across markets
🇺🇸 United States85.3%
🇮🇳 India14.7%
Patent intelligence
$13M patent portfolio · 10 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$13M
1.2% of market cap · 41.7× smaller than top peer ChemoCentryx ($524M)
10 active patent families
Where Calliditas innovates
DrugPharmaceutical drugOrganic chemistryBudesonideGastrointestinal tract
Above peer median on Strategic · Below peer median on Market, Economic
Quality vs same-sector peers
Calliditas on the five Patsnap quality dimensions
Calliditas in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Calliditas concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Calliditas and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Calliditas on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.